Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 1.9B | 1.8B | 2.2B |
Cost of revenue | 394.6M | 378.8M | 369.7M | 392.1M |
Gross profit | 1.7B | 1.6B | 1.4B | 1.8B |
Operating expense | ||||
Research & development | 490.1M | 493.6M | 475.7M | 509.7M |
Selling general and admin | 619.4M | 565.3M | 617.0M | 619.9M |
Other operating expenses | — | — | — | — |
Operating income | 574.4M | 499.0M | 432.4M | 701.0M |
Non operating interest income | ||||
Income | 85.3M | 89.6M | 72.4M | 83.7M |
Expense | 37.1M | 40.1M | 45.2M | 55.9M |
Other income expense | 156.0M | 159.2M | -129.4M | 249.4M |
Pretax income | 778.6M | 707.8M | 330.2M | 978.3M |
Tax provision | 139.8M | 89.3M | 73.7M | 101.0M |
Net income | 683.4M | 604.1M | 306.8M | 955.5M |
Basic EPS | 7.3 | 6.5 | 3.3 | 10.4 |
Diluted EPS | 7.0 | 6.1 | 3.1 | 9.9 |
Basic average shares | 92.4M | 92.5M | 91.9M | 91.4M |
Diluted average shares | 97.4M | 98.3M | 97.8M | 95.4M |
EBITDA | 815.7M | 747.8M | 375.4M | 1.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -4.8M | -5.2M | -4.8M | -8.1M |
Preferred stock dividends | — | — | — | — |